1. NICE recommends life-changing gene therapy for children with ultra-rare genetic disorder in final draft guidance (2023). www.nice.org.uk/news/article/nice-recommends-life-changing-gene-therapy-for-children-with-ultra-rare-genetic-disorder-in-final-draft-guidance
2. SR One closes second venture fund at $600 M. SR One press. www.srone.com/news-input/sr-one-adds-venture-partners-to-deepen-operational-expertise-87wze-4kyyk
3. Lilly cuts insulin prices by 70% and caps patient insulin out-of-pocket costs at $35 per month. https://investor.lilly.com/news-releases/news-release-details/lilly-cuts-insulin-prices-70-and-caps-patient-insulin-out-pocket
4. Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance. Sanofi Press (2023). www.sanofi.com/en/media-room/press-releases/2023/2023-03-16-20-06-43-2629188
5. Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024. Novo Nordisk Press (2023). www.novonordisk.com/news-and-media/latest-news/lowering-us-list-prices-of-several-products-html